Pharma Veterans

Dear Colleagues!  Today is Pharma Veterans Blog Post #180. Pharma Veterans shares the wealth of knowledge and wisdom of Veterans for the benefit of entire Pharma Community. It aims to recognize and celebrate the Pharma Industry Professionals.  Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site.  If you wish to share your stories, ideas and thoughts, please email to asrar@asrarqureshi.com for publishing your contributions here . Continued from Previous…… Questions about Results of Randomized Clinical Trials (RCTs) Most information, and excerpts, for this part has been taken from the published article Rabaeus M et al. Recent Flaws in Evidence-Based Medicine: Statin Effects in Primary Prevention and Consequences of Suspending the Treatment. J Controversies Biomed Res 2017;3(1):1–10. 1 Statin therapy is being promoted by the pharmaceutical companies as a protection against ischemic heart disease (IHD) complications. It

Dear Colleagues!  Today is Pharma Veterans Blog Post #179. Pharma Veterans shares the wealth of knowledge and wisdom of Veterans for the benefit of entire Pharma Community. It aims to recognize and celebrate the Pharma Industry Professionals.  Pharma Veterans Blog  is published by Asrar Qureshi on WordPress , the top blog site.  If you wish to share your stories, ideas and thoughts, please email to asrar@asrarqureshi.com for publishing your contributions here . Continued from Previous…… Controversy about Statins Most information, and excerpts, for this part have been taken from the published article ‘Cholesterol confusion and statin controversy’ DuBroff R, de Lorgeril M. Cholesterol confusion and statin controversy.  World J Cardiol  2015; 7(7): 404-409 1 Since the statins were introduced more than twenty years ago, the case for use of statins has been consistently built up through various clinical trials. The first major study, the 4S study demonst